Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bexxar Consolidation in DLBCL Following CHOP
NCT01868035Phase 2Completed
- Sponsor
- GSK
- Start
- May 2000
- Primary completion
- Oct 2012
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of tositumomab in diffuse large B-cell lymphoma (DLBCL), sponsored by GSK. Started May 2000; status: completed.
02
Drugs
tositumomab
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT01868035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01868035.